Recent Updates
Recently added Catalysts
PLRX Positive Sentiment Score: 65/100

Pliant Therapeutics to Participate in Upcoming Investor Conferences

Tuesday, July 25, 2023 1 min read
Key Takeaway: Pliant Therapeutics, a clinical-stage biotechnology firm, has announced its participation in two upcoming investor conferences in August. The company will engage investors during the BTIG Virtual Biotechnology Conference on August 7th, followed by a fireside chat at the Canaccord Genuity 43rd Annual Growth Conference on August 10th. The events are aimed at broadening Pliant’s visibility among investors and sharing insights on its novel therapeutics for fibrosis.

Market Sentiment Analysis

POSITIVE FACTORS

  • Pliant Therapeutics is actively engaging with investors.
  • Participation in notable investor conferences can enhance visibility.
  • The company is led by experienced professionals in the biotech field.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced participation in the following August investor conferences.
BTIG Virtual Biotechnology Conference 2023 Members of senior management will meet with investors on Monday, August 7th.
Canaccord Genuity 43rd Annual Growth Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat on Thursday, August 10th at 10:00 am Eastern Time.
Interested parties may access the live webcast of the Canaccord Genuity fireside chat by visiting the Investor Relations’ Events & Presentation page of Pliant’s website. The webcast replay will be archived on the Pliant website for 30 days following the conclusion of the event.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.

Frequently Asked Questions

When is Pliant Therapeutics participating in investor conferences?

Pliant Therapeutics will participate in two investor conferences in August 2023.

Who will represent Pliant at the Canaccord Genuity conference?

Bernard Coulie, M.D., Ph.D., and Éric Lefebvre, M.D., will represent Pliant.

How can I access the Canaccord fireside chat?

The fireside chat can be accessed via the Investor Relations page on Pliant's website.

Is there a replay available for the webcast?

Yes, the webcast replay will be available for 30 days after the event.

When is the BTIG Virtual Biotechnology Conference?

The BTIG Virtual Biotechnology Conference will occur on Monday, August 7th.

Tags: PLRX Viatris Investor Conferences Healthcare Pliant Therapeutics investor conferences biotech fibrosis
Last updated: Jul 25, 2023